Ngā hua rapu - Abraham Varghese
- E whakaatu ana i te 1 - 7 hua o te 7
-
1
Obstructive Sleep Apnea in Young Lean Men: Impact on insulin sensitivity and secretion mā Pamidi, Sushmita, Wroblewski, Kristen, Broussard, Josiane, Day, Andrew, Hanlon, Erin C., Abraham, Varghese, Tasali, Esra
I whakaputaina 2012Text -
2
Effect of One Week of 8-Hour Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes: A Proof-of-Concept Study mā Mokhlesi, Babak, Grimaldi, Daniela, Beccuti, Guglielmo, Abraham, Varghese, Whitmore, Harry, Delebecque, Fanny, Van Cauter, Eve
I whakaputaina 2016Text -
3
-
4
-
5
Storage Conditions of Conjugated Reagents Can Impact Results of Immunogenicity Assays mā Kubiak, Robert J., Lee, Nancy, Zhu, Yuan, Franch, William R., Levitskaya, Sophia V., Krishnan, Surekha R., Abraham, Varghese, Akufongwe, Peter F., Larkin, Christopher J., White, Wendy I.
I whakaputaina 2016Text -
6
Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study mā Peter Hillmen, John G. Gribben, George Follows, Donald Milligan, Hazem A. Sayala, Paul Moreton, David Oscier, Claire Dearden, Daniel B. Kennedy, Andrew R. Pettitt, Amit Nathwani, Abraham Varghese, D. Cohen, Andy C. Rawstron, Stephan Oertel, Christopher Pocock
I whakaputaina 2014Artigo -
7
Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia mā Christopher Parrish, Gina B. Scott, G Migneco, Karen J. Scott, Lynette P. Steele, Elizabeth J. Ilett, Emma J. West, Kathryn Hall, Peter J. Selby, David L. Buchanan, Abraham Varghese, Mark S. Cragg, Matt Coffey, Peter Hillmen, Alan Melcher, Fiona Errington‐Mais
I whakaputaina 2015Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Leukemia
Chronic lymphocytic leukemia
Internal medicine
Medicine
Adverse effect
Antibody
Antibody-dependent cell-mediated cytotoxicity
Biochemistry
Biology
CD20
Cancer research
Chemotherapy
Chlorambucil
Clinical endpoint
Clinical trial
Cyclophosphamide
Cytotoxic T cell
Cytotoxicity
Fludarabine
Gastroenterology
Gene
Histone
Histone deacetylase
Immune system
Immunology
Immunotherapy
In vitro
Leukopenia
Lymphoma
Minimal residual disease